REVLIMID

Capsule, hard, 5mg
RxActive license

Active substance (INN)

lenalidomide

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength5mg
PackagingUkupno 21 kapsula tvrda u blisteru (3x7) u kartonskoj kutiji
ManufacturerCelgene Distribution B.V., Netherlands
Therapeutic groupAntineoplastic and immunomodulating agents (L04AX04)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateDecember 24, 2024

Analogs in Montenegro

18

Other medicines with the same active substance

Source: CInMED register